NeuroMetrix Quell™ Wearable Pain Relief Technology Attracts Broad Attention at International Consumer Electronics Show

2015 International CES

WALTHAM, Mass.--()--NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Quell has been featured in several forums during this year’s International Consumer Electronics Show (CES). Among the highlights:

Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. Users of the device will also have the option of using their smartphone to automatically track and personalize their pain therapy.

Consumers and medical professionals can visit QuellRelief.com to learn more and sign up to receive information. The company expects to begin taking pre-orders for Quell in March and to ship during the second quarter. Quell will initially be available exclusively through doctor’s office and online.

About NeuroMetrix

NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. For more information, please visit http://www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com